NO970829L - Antigene peptider avledet fra G-proteinet av RSV for type- og subtype-spesifikk diagnose av respiratorisk syncytisk (RSV) virus-infeksjon - Google Patents

Antigene peptider avledet fra G-proteinet av RSV for type- og subtype-spesifikk diagnose av respiratorisk syncytisk (RSV) virus-infeksjon

Info

Publication number
NO970829L
NO970829L NO970829A NO970829A NO970829L NO 970829 L NO970829 L NO 970829L NO 970829 A NO970829 A NO 970829A NO 970829 A NO970829 A NO 970829A NO 970829 L NO970829 L NO 970829L
Authority
NO
Norway
Prior art keywords
rsv
respiratory syncytial
protein
syncytial virus
subtypes
Prior art date
Application number
NO970829A
Other languages
English (en)
Norwegian (no)
Other versions
NO970829D0 (no
Inventor
Johannes Petrus Mari Langedijk
Original Assignee
Instituut Voor Dierhouderij En
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituut Voor Dierhouderij En filed Critical Instituut Voor Dierhouderij En
Publication of NO970829D0 publication Critical patent/NO970829D0/no
Publication of NO970829L publication Critical patent/NO970829L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO970829A 1994-08-25 1997-02-24 Antigene peptider avledet fra G-proteinet av RSV for type- og subtype-spesifikk diagnose av respiratorisk syncytisk (RSV) virus-infeksjon NO970829L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202440 1994-08-25
PCT/NL1995/000279 WO1996006112A1 (en) 1994-08-25 1995-08-22 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection

Publications (2)

Publication Number Publication Date
NO970829D0 NO970829D0 (no) 1997-02-24
NO970829L true NO970829L (no) 1997-04-18

Family

ID=8217137

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970829A NO970829L (no) 1994-08-25 1997-02-24 Antigene peptider avledet fra G-proteinet av RSV for type- og subtype-spesifikk diagnose av respiratorisk syncytisk (RSV) virus-infeksjon

Country Status (10)

Country Link
US (1) US6077511A (de)
EP (1) EP0777685B1 (de)
JP (1) JPH10512846A (de)
AT (1) ATE178906T1 (de)
AU (1) AU710713B2 (de)
CA (1) CA2198279A1 (de)
DE (1) DE69509103T2 (de)
NO (1) NO970829L (de)
NZ (1) NZ291243A (de)
WO (1) WO1996006112A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO026596A0 (en) * 1996-06-05 1996-06-27 Biomolecular Research Institute Limited Viral peptide
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
JP2004511807A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中のｒｓウイルスに関連した生物学的細胞の直接的検出のためのアッセイ
ES2316487T5 (es) 2000-10-18 2019-05-13 The Government Of The Us Secretary Department Of Health And Human Services Composiciones y métodos para modular la inmunidad e infección de RSV
US6605283B1 (en) 2002-11-01 2003-08-12 The United States Of America As Represented By The Secretary Of Agriculture Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein gene
EA200501285A1 (ru) * 2003-02-11 2006-02-24 Неофарм, Инк. Способ получения липосомальных препаратов
MX2008011280A (es) * 2006-03-06 2008-09-12 Symphogen As Anticuerpor policlonal recombinante para el tratamiento de infecciones por el virus sincitial respiratorio.
MX2009009226A (es) * 2007-03-06 2009-10-28 Symphogen As Anticuerpos recombinantes para el tratamiento de infecciones con el virus respiratorio sincitial.
CA2770304C (en) * 2009-08-04 2019-11-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Anti-rsv immunogens and methods of immunization
CA2799934C (en) 2010-07-07 2020-01-28 Artificial Cell Technologies, Inc. Respiratory syncytial virus antigenic compositions and methods
EA201891945A3 (ru) 2012-08-01 2019-05-31 Бавариан Нордик А/С Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)
EP3833677A4 (de) * 2018-08-08 2022-04-27 Trellis Bioscience, Inc. Verbesserte rsv-passive und -aktive impfstoffe
CN114957407A (zh) 2019-04-02 2022-08-30 赛诺菲 抗原性多聚呼吸道合胞病毒多肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540645A4 (en) * 1990-07-24 1993-12-29 The Uab Research Foundation Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
FR2718452B1 (fr) * 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.

Also Published As

Publication number Publication date
DE69509103T2 (de) 1999-09-30
AU3231695A (en) 1996-03-14
NZ291243A (en) 1998-10-28
DE69509103D1 (de) 1999-05-20
EP0777685B1 (de) 1999-04-14
AU710713B2 (en) 1999-09-30
JPH10512846A (ja) 1998-12-08
NO970829D0 (no) 1997-02-24
CA2198279A1 (en) 1996-02-29
EP0777685A1 (de) 1997-06-11
WO1996006112A1 (en) 1996-02-29
US6077511A (en) 2000-06-20
ATE178906T1 (de) 1999-04-15

Similar Documents

Publication Publication Date Title
NO970829D0 (no) Antigene peptider avledet fra G-proteinet av RSV for type- og subtype-spesifikk diagnose av respiratorisk syncytisk (RSV) virus-infeksjon
RU2220978C2 (ru) Пептид, индуцирующий образование антител, которые реагируют с двумя различными изолятами вррсс (варианты), иммуногенная композиция, вакцина для профилактики заражения репродуктивно-респираторным синдромом свиней, антитело, диагностический набор (варианты)
Bolin et al. Specificity of neutralizing and precipitating antibodies induced in healthy calves by monovalent modified-live bovine viral diarrhea virus vaccines
PT97159A (pt) Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina
DK0610250T3 (da) Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf
Eberle et al. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera
NO976119D0 (no) OMP26-antigen fra Haemophilus influenzae
Kim et al. Respiratory syncytial virus detection by immunofluorescence in nasal secretions with monoclonal antibodies against selected surface and internal proteins
ATE265682T1 (de) Bovine virale diarrhöe virus serumantigen fangimmuntest
EP0602046A4 (de) Detektion des immunschwäche-virus aus säugetieren.
Ristow et al. Detection and characterization of rainbow trout antibody against infectious hematopoietic necrosis virus
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
SE9202968D0 (sv) New peptides, diagnostic antigens, use thereof, vaccines and medicaments
Fulton et al. Immunofluorescence in diagnosis of measles infections in children
KR20140033493A (ko) Ｐｒｒｓ 바이러스 및 이의 단백질의 제조 방법 및 이들의 검출을 위한 진단 검사 키트
Welliver et al. Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine
DE60218321D1 (de) Nachweis des virus der viralen rinderdiarrhoe in gewebsproben
DE69535156D1 (de) Verfahren und zusammensetzungen zur diagnose von rochalimaea henselae und rochalimaea quintana infektion
DE69011122D1 (de) Rubella-e1 und c peptide.
Biedel Recurrent mumps parotitis following natural infection and immunization
DE69934098D1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
Sprino et al. Intestinal immune response of feeder pigs to infection with transmissible gastroenteritis virus
Pauli et al. Biology and molecular biology of latent bovine herpes virus type 1 (BHV-1)
RU93039551A (ru) Способ получения специфической сыворотки для лечения, диагностики и профилактики вирусной геморрагической болезни кроликов и набор для диагностики болезни
Hall et al. Brucella abortus-specific immunoglobulin in isotypes in serum and vaginal mucus from cattle vaccinated with strain 19 and challenge exposed with virulent strain 2308

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application